Wakefit IPO Allotment Status: Check Latest GMP, Steps To Verify Status

Wakefit’s IPO has stirred strong interest from both retail and institutional investors. If you’ve applied, you’re probably eager to know whether you got an allotment—and what the grey market premium (GMP) is signaling.

Here’s everything you need to know about checking the Wakefit IPO allotment status and tracking the latest GMP update.

Wakefit IPO Allotment Status – How to Check

IPO allotment results are typically released a few days after the IPO closes. For Wakefit, the allotment status can be checked online using your PAN number, application number, or DP/Client ID.

Steps to Check Wakefit IPO Allotment Status:

You can check your status through either the registrar’s website or the Bombay Stock Exchange (BSE).

Option 1: Registrar Website

  1. Go to the registrar’s official IPO allotment page.
  2. Select Wakefit Innovations Limited from the dropdown.
  3. Choose from:
    • PAN Number
    • Application Number
    • DP/Client ID
  4. Enter the required details and captcha.
  5. Click Submit to view your allotment status.

Option 2: BSE Website

  1. Visit bseindia.com/investors/appli_check.aspx
  2. Select Equity.
  3. Choose Wakefit from the dropdown.
  4. Enter your PAN and application number.
  5. Click Search.

Wakefit IPO GMP Today: Grey Market Premium Update

The Grey Market Premium (GMP) is an unofficial but popular way to gauge investor sentiment before listing. It can hint at potential listing day gains, though it’s not a guarantee.

Latest Wakefit IPO GMP & Subscription Data (as of December 11, 2025)

Grey Market Premium (GMP) gives a rough indication of how investors are pricing the IPO unofficially before it lists. It can change daily and doesn’t guarantee actual listing performance.

  • GMP: ₹2 per share (unofficial grey market estimate)
  • Issue Price: ₹195 per share (upper band)
  • Estimated Listing Price: ₹197 per share (₹195 + ₹2)
    (This suggests a modest potential gain if the trend holds.)

Wakefit IPO Subscription Overview

The Wakefit IPO saw strong demand from investors across categories when the subscription period closed on December 10, 2025:

  • Overall Subscription: ~2.52× (total applications were about 2.52 times the shares on offer)
  • Retail Investors: ~3.17×
  • QIB (Qualified Institutional Buyers): ~3.04×
  • NII (Non‑Institutional Investors): ~1.05×

These figures show solid participation, especially from retail and institutional investors, indicating investor interest in the issue.

Important Wakefit IPO Dates

EventDate
IPO Open DateDecember 4, 2025
IPO Close DateDecember 6, 2025
Allotment FinalizationDecember 9, 2025
Refunds InitiatedDecember 10, 2025
Shares Credited to DematDecember 11, 2025
Listing DateDecember 12, 2025

What If You Didn’t Get an Allotment?

If you didn’t receive shares:

  • Your refund will be processed automatically—usually within 2–3 business days.
  • You can still buy Wakefit shares on the listing day, but at the market price through your trading platform.

FAQs

Q. What is Wakefit known for?

Wakefit is a direct-to-consumer home and sleep solutions company, best known for its mattresses, furniture, and ergonomic products.

Q. Is Wakefit a profitable company?

Wakefit has shown strong revenue growth and is expanding aggressively. While it may not be consistently profitable each quarter, its business model and brand are well-recognized.

Q. Can GMP be trusted for investment decisions?

Not entirely. GMP is speculative and not regulated by SEBI. It should be used as a general guide to sentiment—not a basis for financial decisions.

Key Takeaways

  • Check your Wakefit IPO allotment using PAN or application number on the registrar or BSE website.
  • GMP gives an idea of market sentiment but shouldn’t be your only indicator.
  • Refunds and Demat credit are processed shortly before the listing.

Disclaimer

The stocks mentioned in this article are not recommendations. Please conduct your own research and due diligence before investing. Investment in securities market are subject to market risks, read all the related documents carefully before investing. Please read the Risk Disclosure documents carefully before investing in Equity Shares, Derivatives, Mutual fund, and/or other instruments traded on the Stock Exchanges. As investments are subject to market risks and price fluctuation risk, there is no assurance or guarantee that the investment objectives shall be achieved. Lemonn (Formerly known as NU Investors Technologies Pvt. Ltd) do not guarantee any assured returns on any investments. Past performance of securities/instruments is not indicative of their future performance.